Antimicrobial susceptibility patterns of shigella isolates in foodborne diseases active surveillance network (foodnet) sites, 2000-2010

Clinical Infectious Diseases

Volumn 54, Issue SUPPL.5, 2012, Pages

  Shiferaw, Beletshachew ^a   Solghan, Suzanne ^b   Palmer, Amanda ^c   Joyce, Kevin ^d   Barzilay, Ezra J ^d   Krueger, Amy ^d   Cieslak, Paul ^a  

^a OREGON PUBLIC HEALTH DIVISION   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^c MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOXITIN; CEFTIOFUR; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; STREPTOMYCIN; SULFAFURAZOLE; SULFAMETHOXAZOLE; TETRACYCLINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; ETHNIC DIFFERENCE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SHIGELLA; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS; SPECIES DIFFERENCE; TRAVEL; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOODBORNE DISEASES; HISPANIC AMERICANS; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SHIGELLA; TRAVEL; UNITED STATES; YOUNG ADULT;

EID: 84861030736     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis230     Document Type: Article

References (23)

1. Scallan E, et al. Foodborne illness acquired in the United States\major pathogens. Emerg Infect Dis 2011; 17:7-15.
2. Salam MA, Bennish ML. Antimicrobial therapy for shigellosis. Rev Infect Dis 1991; 13(Suppl 4):S332-41.
3. Ashkenazi S, Levy I, Kazaronovski V, Samra Z. Growing antimicrobial resistance of Shigella isolates. J Antimicrob Chemother 2003; 51:427-9.
4. Cheasty T, Skinner JA, Rowe B, Threlfall EJ. Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy. Microb Drug Resist 1998; 4:57-60.
5. Opintan J, Newman MJ. Distribution of serogroups and serotypes of multiple drug resistant Shigella isolates. Ghana Med J 2007; 41:8-29.
6. Kuo CY, Su L, Perera J, et al. Antimicrobial susceptibility of Shigella isolates in eight Asian countries, 2001-2004. J Microbiol Immunol Infect 2008; 41:107-11.
7. Hosseini MJ, Ranjbar R, Ghasemi H, Jalalian HR. The prevalence and antibiotic resistance of Shigella sp. recovered from patients admitted to Bouali Hospital, Tehran, Iran during 1999-2001. Pak J Biol Sci 2007; 10:2778-80.
8. Al-Moyed KA, Harmal NS, Al-Harasy AH, Al-Shamahy HA. Increasing single and multi-antibiotic resistance in Shigella species isolated from shigellosis patients in Sana'a, Yemen. Saudi Med J 2006; 27:1157-60.
9. Shiferaw B, Shallow S, Marcus R, et al. Trends in population-based active surveillance for shigellosis and demographic variability in FoodNet sites, 1996-1999. Clin Infect Dis 2004; 38(Suppl 3):S175-80.
10. Mohle-Boetani JC, Stapleton M, Finger R, et al. Communitywide shigellosis: control of an outbreak and risk factors in child day-care centers. Am J Public Health 1995; 85:812-16.
11. Hoffman RE, Shillam PJ. The use of hygiene, cohorting, and antimicrobial therapy to control an outbreak of shigellosis. Am J Dis Child 1990; 144:219-21.
12. Angulo FJ, Voetsch AC, Vugia D, et al. Determining the burden of human illness from food borne diseases. CDC's emerging infectious disease program Food Borne Diseases Active Surveillance Network (FoodNet). Vet Clin North Am Food Anim Pract 1998; 14:165-72.
13. Centers for Disease Control and Prevention. National Antimicrobial Resistance Monitoring System (NARMS)\about NARMS. Available at: http://www.cdc.gov/narms/about-narms.htm. Published 1 June 2005. Accessed 16 February 2012.
14. Centers for Disease Control and Prevention (CDC).National Antimicrobial Resistance Monitoring System: enteric bacteria. Atlanta, GA: CDC 2010. Available at: http://www.cdc.gov/narms/annual/2008/NARMS-2008-Annual-Report.pdf. Accessed 16 February 2012.
15. Sivapalasingam S, Nelson JM, Joyce K, Hoekstra M, Angulo FJ, Mintz ED. High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrob Agents Chemother 2006; 50:49-54.
16. Replogle ML, Fleming DW, Cieslak PR. Emergence of antimicrobial-resistant shigellosis in Oregon. Clin Infect Dis 2000; 30:515-19.
17. Wong MR, Reddy V, Hanson H, et al. Antimicrobial resistance trends of Shigella serotypes in New York City, 2006-2009. Microb Drug Resist 2010; 16:155-61.
18. Tauxe RV, Puhr ND, Wells JG, Hargrett-Bean N, Blake PA. Antimicrobial resistance of Shigella isolates in the USA: the importance of international travelers. J Infect Dis 1990; 162:1107-11.
19. Haukka K, Siitonen A. Emerging resistance to newer antimicrobial agents among Shigella isolated from Finnish foreign travellers. Epidemiol Infect 2008; 136:476-82.
20. Scallan E. Activities, achievements, and lessons learned during the first 10 years of the Foodborne Diseases Active Surveillance Network: 1996-2005. Clin Infect Dis 2007; 44:718-25.
21. Weissman JB, Gangarosa EJ, DuPont HL. Changing needs in the antimicrobial therapy of shigellosis. J Infect Dis 1973; 127:611-13.
22. Basualdo W, Arbo A. Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children. Pediatr Infect Dis J 2003; 22:374-7.
23. Mensa L, Marco F, Vila J, Gascon J, Ruiz J. Quinolone resistance among Shigella spp. isolated from travellers returning from India. Clin Mi-crobiol Infect 2008; 14:279-81.